Bryan Mann, MBA
About Bryan Mann, MBA
Bryan Mann, MBA, is the Director of Project Realization at Bristol-Myers Squibb with over 30 years of experience in the pharmaceutical industry.
Current Role at Bristol-Myers Squibb
Bryan Mann is currently serving as the Director of Project Realization at Bristol-Myers Squibb. In this position since January 2013, he has been responsible for leading capital projects within the company. His role involves overseeing the successful execution and completion of key projects, utilizing his extensive background in project management and engineering.
Previous Experience at Roche Pharmaceuticals
From 1990 to 2012, Bryan Mann worked at Roche Pharmaceuticals as a Project Manager. During his 22-year tenure, he contributed to numerous significant projects and gained valuable experience in project management within the pharmaceutical industry. His long-term commitment to Roche Pharmaceuticals underscores his expertise and dedication to the field.
Background at Schering-Plough Research Institute
Before joining Roche Pharmaceuticals, Bryan Mann worked as a Project Engineer at Schering-Plough Research Institute in Kenilworth, NJ. He held this role from 1981 to 1990, accumulating nine years of experience. His work at Schering-Plough provided him with a solid foundation in the pharmaceutical industry and equipped him with necessary engineering skills.
Educational Background
Bryan Mann holds a Master of Business Administration (M.B.A.) in Pharmaceutical Studies from Fairleigh Dickinson University. Additionally, he earned a Bachelor of Science (BSc) in Chemical Engineering from Rutgers University College of Engineering. His educational background has fortified his expertise in both chemical engineering and pharmaceutical studies, aligning with his extensive experience in the industry.
Expertise in Pharmaceutical Industry
With over 30 years of experience in the pharmaceutical industry, Bryan Mann brings a wealth of knowledge to his current role. His expertise spans project management, engineering, and the execution of capital projects. His background in both chemical engineering and pharmaceutical studies enables him to effectively lead complex projects, contributing significantly to his current and previous professional roles.